Showing results (41-50 of 92) with videos related to
Sort By:
Pageof 10
Investigative Ophthalmology & Visual Science|December 19, 2022
Different Murine High-Risk Corneal Transplant Settings Vary Significantly in Their (Lymph)angiogenic and Inflammatory Cell SignaturesWei Zhang, Alfrun Schönberg, Fiona Bassett, et al.The Journal of Experimental Medicine|May 4, 2011
Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytesClaus Cursiefen, Kazuichi Maruyama, Felix Bock, et al.Communications Biology|September 10, 2022
Cystathionine β-synthase as novel endogenous regulator of lymphangiogenesis via modulating VEGF receptor 2 and 3Niloofar Hatami, Christian Büttner, Felix Bock, et al.International Journal of Molecular Sciences|February 15, 2022
New Therapeutic Approaches for Conjunctival Melanoma-What We Know So Far and Where Therapy Is Potentially Heading: Focus on Lymphatic Vessels and Dendritic CellsJennifer Peil, Felix Bock, Friedemann Kiefer, et al.Journal of Clinical Medicine|August 10, 2024
Selective, Temporary Postoperative Inhibition of Lymphangiogenesis by Integrin α5β1 Blockade Improves Allograft Survival in a Murine Model of High-Risk Corneal TransplantationTina Dietrich-Ntoukas, Felix Bock, Jasmine Onderka, et al.The American Journal of Pathology|June 27, 2007
Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockadeTina Dietrich, Jasmine Onderka, Felix Bock, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 2, 2019
Local VEGF-A blockade modulates the microenvironment of the corneal graft bedAnn-Charlott Salabarria, Gabriele Braun, Malte Heykants, et al.Investigative Ophthalmology & Visual Science|November 18, 2017
Label-Free In Vivo Imaging of Corneal Lymphatic Vessels Using Microscopic Optical Coherence TomographyJens Horstmann, Hinnerk Schulz-Hildebrandt, Felix Bock, et al.The American Journal of Pathology|November 19, 2018
Tyrosinase Is a Novel Endogenous Regulator of Developmental and Inflammatory LymphangiogenesisChristian Büttner, Thomas Clahsen, Birgit Regenfuss, et al.Investigative Ophthalmology & Visual Science|May 26, 2007
Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesisFelix Bock, Jasmine Onderka, Tina Dietrich, et al.Pageof 10